Alimetry is taking the next steps in gastric dysfunction diagnosis and treatment. The company has developed a non-invasive wearable device for real-time gastric mapping, symptom tracking, and analysis, resulting in a rapid and objective diagnostics tool for a variety of GI disorders. This greatly reduces the uncertainties and trauma currently associated with a gastric disorder diagnosis.

Based in Auckland, Alimetry is built on a decade of scientific and technological research in the GI field, and led by an executive team with internationally respected medical, technological, and med-tech commercialisation experience. Our support to Alimetry has helped to direct their long-term operational strategy and governance, as well as utilising our connections with international markets.